BPMC
Price
$96.88
Change
+$0.26 (+0.27%)
Updated
Nov 13 closing price
91 days until earnings call
KRYS
Price
$184.22
Change
-$3.00 (-1.60%)
Updated
Nov 13 closing price
109 days until earnings call
Ad is loading...

BPMC vs KRYS

Header iconBPMC vs KRYS Comparison
Open Charts BPMC vs KRYSBanner chart's image
Blueprint Medicines
Price$96.88
Change+$0.26 (+0.27%)
Volume$366.31K
CapitalizationN/A
Krystal Biotech
Price$184.22
Change-$3.00 (-1.60%)
Volume$201.97K
CapitalizationN/A
BPMC vs KRYS Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BPMC vs. KRYS commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Buy and KRYS is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (BPMC: $96.88 vs. KRYS: $184.22)
Brand notoriety: BPMC and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 56% vs. KRYS: 85%
Market capitalization -- BPMC: $6.15B vs. KRYS: $5.3B
BPMC [@Biotechnology] is valued at $6.15B. KRYS’s [@Biotechnology] market capitalization is $5.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 5 bullish TA indicator(s).

  • BPMC’s TA Score: 5 bullish, 5 bearish.
  • KRYS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BPMC and KRYS are a good buy in the short-term.

Price Growth

BPMC (@Biotechnology) experienced а -2.76% price change this week, while KRYS (@Biotechnology) price change was +0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

BPMC is expected to report earnings on Feb 13, 2025.

KRYS is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($6.15B) has a higher market cap than KRYS($5.3B). KRYS YTD gains are higher at: 48.493 vs. BPMC (5.030). KRYS has higher annual earnings (EBITDA): 120M vs. BPMC (-75.58M). BPMC has more cash in the bank: 734M vs. KRYS (560M). KRYS has less debt than BPMC: KRYS (7.69M) vs BPMC (471M). BPMC has higher revenues than KRYS: BPMC (434M) vs KRYS (166M).
BPMCKRYSBPMC / KRYS
Capitalization6.15B5.3B116%
EBITDA-75.58M120M-63%
Gain YTD5.03048.49310%
P/E RatioN/A103.49-
Revenue434M166M261%
Total Cash734M560M131%
Total Debt471M7.69M6,127%
FUNDAMENTALS RATINGS
BPMC vs KRYS: Fundamental Ratings
BPMC
KRYS
OUTLOOK RATING
1..100
207
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
736
SMR RATING
1..100
9658
PRICE GROWTH RATING
1..100
4643
P/E GROWTH RATING
1..100
7699
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BPMC's Valuation (80) in the Biotechnology industry is in the same range as KRYS (84) in the Pharmaceuticals Major industry. This means that BPMC’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (6) in the Pharmaceuticals Major industry is significantly better than the same rating for BPMC (73) in the Biotechnology industry. This means that KRYS’s stock grew significantly faster than BPMC’s over the last 12 months.

KRYS's SMR Rating (58) in the Pharmaceuticals Major industry is somewhat better than the same rating for BPMC (96) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than BPMC’s over the last 12 months.

KRYS's Price Growth Rating (43) in the Pharmaceuticals Major industry is in the same range as BPMC (46) in the Biotechnology industry. This means that KRYS’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (76) in the Biotechnology industry is in the same range as KRYS (99) in the Pharmaceuticals Major industry. This means that BPMC’s stock grew similarly to KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCKRYS
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 1 day ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SSG26.720.88
+3.41%
ProShares UltraShort Semiconductors
CNXT31.540.64
+2.07%
VanEck ChiNext ETF
STOT46.970.04
+0.09%
SPDR® DoubleLine Shrt Dur Ttl RetTactETF
DIVO41.800.03
+0.07%
Amplify CWP Enhanced Dividend Income ETF
QQH66.75-0.09
-0.13%
HCM Defender 100 Index ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with BBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
+0.27%
BBIO - BPMC
45%
Loosely correlated
+0.69%
DNLI - BPMC
45%
Loosely correlated
-0.84%
SNDX - BPMC
44%
Loosely correlated
+2.65%
KRYS - BPMC
44%
Loosely correlated
-1.60%
RCKT - BPMC
43%
Loosely correlated
-2.25%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-1.60%
CLDX - KRYS
54%
Loosely correlated
-0.63%
BEAM - KRYS
46%
Loosely correlated
-1.57%
SNDX - KRYS
46%
Loosely correlated
+2.65%
ZLDPF - KRYS
45%
Loosely correlated
-3.43%
RXRX - KRYS
44%
Loosely correlated
-3.56%
More